Gisondi, Paolo, Francesco Loconsole, Paola Raimondo, and Roberto Ravasio. 2021. “Cost Per Responder for Risankizumab Vs Secukinumab in Patients With Moderate-to-Severe Plaque Psoriasis in Italy”. Global and Regional Health Technology Assessment 8 (1):120-30. https://doi.org/10.33393/grhta.2021.2258.